Claes Lindberg

AstraZeneca (Sweden)

Papers

1

Total Citations

7

H-Index

1

About

Claes Lindberg is a distinguished researcher in the field of bioanalytical chemistry, with a primary focus on the quantification of complex biological molecules, particularly mucins, in respiratory samples. His most cited work, a 2012 study on liquid chromatography–tandem mass spectrometry (LC-MS/MS) for quantifying mucins from sputum, introduced a groundbreaking method using ¹³C,¹⁵N-labeled peptides as internal standards. This approach significantly enhanced the accuracy and reproducibility of mucin measurement, which is critical for understanding airway diseases such as cystic fibrosis and chronic obstructive pulmonary disease. With 7 citations, this paper has provided a foundational tool for researchers studying mucus composition and its role in respiratory health. Lindberg’s contributions have advanced the application of mass spectrometry in clinical biochemistry, enabling more precise biomarker analysis. His work is particularly notable for bridging analytical chemistry and pulmonary medicine, offering a reliable technique that has been adopted in subsequent studies. Through his innovative methodology, Lindberg has helped pave the way for more targeted therapeutic strategies in respiratory disease management.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Liquid chromatography–tandem mass spectrometry approach for quantification of mucins from sputum using 13C,15N-labeled peptides as internal standards
7 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: AstraZeneca (Sweden)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago